rs61735813

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_006031.6(PCNT):​c.6957T>G​(p.Phe2319Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0013 in 1,609,758 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0011 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0013 ( 12 hom. )

Consequence

PCNT
NM_006031.6 missense

Scores

1
18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:5

Conservation

PhyloP100: -0.0790

Publications

10 publications found
Variant links:
Genes affected
PCNT (HGNC:16068): (pericentrin) The protein encoded by this gene binds to calmodulin and is expressed in the centrosome. It is an integral component of the pericentriolar material (PCM). The protein contains a series of coiled-coil domains and a highly conserved PCM targeting motif called the PACT domain near its C-terminus. The protein interacts with the microtubule nucleation component gamma-tubulin and is likely important to normal functioning of the centrosomes, cytoskeleton, and cell-cycle progression. Mutations in this gene cause Seckel syndrome-4 and microcephalic osteodysplastic primordial dwarfism type II. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
PCNT Gene-Disease associations (from GenCC):
  • microcephalic osteodysplastic primordial dwarfism type II
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Moyamoya disease
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0044552684).
BP6
Variant 21-46418239-T-G is Benign according to our data. Variant chr21-46418239-T-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 159646.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.00132 (1918/1457374) while in subpopulation MID AF = 0.0052 (30/5766). AF 95% confidence interval is 0.00374. There are 12 homozygotes in GnomAdExome4. There are 967 alleles in the male GnomAdExome4 subpopulation. Median coverage is 28. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 12 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PCNTNM_006031.6 linkc.6957T>G p.Phe2319Leu missense_variant Exon 31 of 47 ENST00000359568.10 NP_006022.3 O95613-1
PCNTNM_001315529.2 linkc.6603T>G p.Phe2201Leu missense_variant Exon 31 of 47 NP_001302458.1 O95613-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PCNTENST00000359568.10 linkc.6957T>G p.Phe2319Leu missense_variant Exon 31 of 47 1 NM_006031.6 ENSP00000352572.5 O95613-1

Frequencies

GnomAD3 genomes
AF:
0.00110
AC:
167
AN:
152266
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00124
Gnomad ASJ
AF:
0.0245
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000794
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00175
AC:
441
AN:
251296
AF XY:
0.00166
show subpopulations
Gnomad AFR exome
AF:
0.0000616
Gnomad AMR exome
AF:
0.00124
Gnomad ASJ exome
AF:
0.0262
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000985
Gnomad OTH exome
AF:
0.00326
GnomAD4 exome
AF:
0.00132
AC:
1918
AN:
1457374
Hom.:
12
Cov.:
28
AF XY:
0.00133
AC XY:
967
AN XY:
725380
show subpopulations
African (AFR)
AF:
0.000180
AC:
6
AN:
33316
American (AMR)
AF:
0.00134
AC:
60
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.0253
AC:
660
AN:
26104
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39680
South Asian (SAS)
AF:
0.0000580
AC:
5
AN:
86150
European-Finnish (FIN)
AF:
0.0000562
AC:
3
AN:
53412
Middle Eastern (MID)
AF:
0.00520
AC:
30
AN:
5766
European-Non Finnish (NFE)
AF:
0.000899
AC:
996
AN:
1108002
Other (OTH)
AF:
0.00262
AC:
158
AN:
60230
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
87
173
260
346
433
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00110
AC:
167
AN:
152384
Hom.:
1
Cov.:
33
AF XY:
0.00102
AC XY:
76
AN XY:
74516
show subpopulations
African (AFR)
AF:
0.000144
AC:
6
AN:
41596
American (AMR)
AF:
0.00124
AC:
19
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.0245
AC:
85
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000794
AC:
54
AN:
68038
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
9
18
28
37
46
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00196
Hom.:
4
Bravo
AF:
0.00124
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00267
AC:
23
ExAC
AF:
0.00143
AC:
174
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00207
EpiControl
AF:
0.00142

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Microcephalic osteodysplastic primordial dwarfism type II Uncertain:1Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Jul 28, 2020
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 01, 2016
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PCNT: BP4, BS2 -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.35
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.77
CADD
Benign
2.5
DANN
Benign
0.63
DEOGEN2
Benign
0.016
T
Eigen
Benign
-0.80
Eigen_PC
Benign
-0.66
FATHMM_MKL
Benign
0.38
N
LIST_S2
Benign
0.52
T
M_CAP
Benign
0.0069
T
MetaRNN
Benign
0.0045
T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
0.20
N
PhyloP100
-0.079
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-0.81
N
REVEL
Benign
0.080
Sift
Benign
0.89
T
Sift4G
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.030
MutPred
0.088
Gain of helix (P = 0.0325);
MVP
0.23
MPC
0.094
ClinPred
0.0072
T
GERP RS
0.84
Varity_R
0.034
gMVP
0.12
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61735813; hg19: chr21-47838153; API